Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Mugs your comment on CEO CA
View:
Post by WalkOverTheStrt on Aug 14, 2021 10:10pm

Mugs your comment on CEO CA

Can you expound on your comment on ATE board on CEO CA (below)? It sounds negative but I'd like you to clarify as you've been silent here but still (assume that alias is yours) more often. 


"@MUGMODs If we go below 100 mg ... I wouldn't bet on any dose, I wouldn't bet on linearity, I just wouldn't bet on an endpoint".


https://ceo.ca/ate?6f511046e466
Comment by MrMugsy on Aug 15, 2021 11:48am
No WalkingOverTheStrt ... I'm not negative on the company. I think we have plenty of options, even if we don't go below 100 mg ... we have good options but there are always trade-offs with options. There are too many ugly people here (also at CEO) and I share very little these days. I'm no longer share much here - more privately. To answer your question specifically ... If 346 is ...more  
Comment by WalkOverTheStrt on Aug 17, 2021 9:53am
Thanks Mugs and my applogies for coloring your comments with my view / words.  Well at least mgmt has more than enough data to review from the AME to determine the right next steps. This will be a long wait (Oct) but not much we can do. Thankfully the next steps / analysis is before the height of tax selling so a chance we could see a reversal. One can hope "During the course of the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities